KR20090019926A - 유착, 관절염 및 건선 치료에 있어서 푸칸의 용도 - Google Patents

유착, 관절염 및 건선 치료에 있어서 푸칸의 용도 Download PDF

Info

Publication number
KR20090019926A
KR20090019926A KR1020097002751A KR20097002751A KR20090019926A KR 20090019926 A KR20090019926 A KR 20090019926A KR 1020097002751 A KR1020097002751 A KR 1020097002751A KR 20097002751 A KR20097002751 A KR 20097002751A KR 20090019926 A KR20090019926 A KR 20090019926A
Authority
KR
South Korea
Prior art keywords
fucan
composition
pharmaceutical composition
fucoidan
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020097002751A
Other languages
English (en)
Korean (ko)
Inventor
존 케이. 잭슨
헬렌 엠. 버트
Original Assignee
더 유니버시티 오브 브리티쉬 콜롬비아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 유니버시티 오브 브리티쉬 콜롬비아 filed Critical 더 유니버시티 오브 브리티쉬 콜롬비아
Publication of KR20090019926A publication Critical patent/KR20090019926A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020097002751A 2001-08-29 2002-08-29 유착, 관절염 및 건선 치료에 있어서 푸칸의 용도 Ceased KR20090019926A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31536201P 2001-08-29 2001-08-29
US60/315,362 2001-08-29

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020047003089A Division KR100910246B1 (ko) 2001-08-29 2002-08-29 유착, 관절염 및 건선 치료에 있어서 푸칸의 용도

Publications (1)

Publication Number Publication Date
KR20090019926A true KR20090019926A (ko) 2009-02-25

Family

ID=23224048

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020097002751A Ceased KR20090019926A (ko) 2001-08-29 2002-08-29 유착, 관절염 및 건선 치료에 있어서 푸칸의 용도
KR1020047003089A Expired - Fee Related KR100910246B1 (ko) 2001-08-29 2002-08-29 유착, 관절염 및 건선 치료에 있어서 푸칸의 용도

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020047003089A Expired - Fee Related KR100910246B1 (ko) 2001-08-29 2002-08-29 유착, 관절염 및 건선 치료에 있어서 푸칸의 용도

Country Status (15)

Country Link
US (3) US6812220B2 (https=)
EP (1) EP1420801B1 (https=)
JP (2) JP4758063B2 (https=)
KR (2) KR20090019926A (https=)
CN (2) CN101028283A (https=)
AT (1) ATE376835T1 (https=)
AU (1) AU2002325113B2 (https=)
CA (1) CA2458853C (https=)
DE (1) DE60223262T2 (https=)
DK (1) DK1420801T3 (https=)
ES (1) ES2295386T3 (https=)
MX (1) MXPA04001876A (https=)
NZ (2) NZ532015A (https=)
PT (1) PT1420801E (https=)
WO (1) WO2003018033A1 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632456B1 (en) * 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
US8163726B2 (en) * 2002-09-18 2012-04-24 University Of Pennsylvania Method of inhibiting choroidal neovascularization
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8137688B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8138265B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
WO2004078210A1 (ja) 2003-03-06 2004-09-16 Takashi Muramatsu 開腹手術後の癒着の予防剤
JP2007504273A (ja) * 2003-05-30 2007-03-01 エーアールシー ファーマシューティカルズ，インク． 種々の作用剤を用いた、線維性癒着の抑制に関する医薬組成物及び方法
CA2539324A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
WO2005089800A1 (ja) * 2004-03-17 2005-09-29 Locomogene, Inc. hsHRD3を含む医薬組成物
AU2005265326B2 (en) * 2004-07-09 2010-07-15 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
ES2729826T3 (es) * 2004-09-23 2019-11-06 Arc Medical Devices Inc Composiciones farmacéuticas y métodos relacionados para inhibir adherencias fibrosas o enfermedad inflamatoria usando fucanos con bajo contenido de sulfato
JP4974903B2 (ja) 2005-02-09 2012-07-11 参天製薬株式会社 疾患または状態を処置するための液体処方物
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
AU2006214892B2 (en) * 2005-02-16 2013-06-27 Kt & G Co., Ltd Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
US20060210515A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Hair growth formula
US20060210692A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Baby food composition
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US20060210514A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin protection and moisturizing compositions and method of making the same
US20060210496A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Compositions for skin protection from ultraviolet damage
US7776365B2 (en) * 2005-03-18 2010-08-17 Sakura Properties, Llc Article with skin protecting and moisturizing compound
US7666448B2 (en) * 2005-03-18 2010-02-23 Sakura Properties, Llc Skin cleansing article
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210688A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Dehydrated sports drink powder
KR101332869B1 (ko) 2005-04-15 2013-11-25 알버트 아인슈타인 컬리지 오브 메디신 오브 예쉬바 유니버시티 항-ｅｇｆｒ 치료법에 속발된 피부 발진의 예방 및 치료를위한 비타민 ｋ
US20070003669A1 (en) * 2005-06-02 2007-01-04 Troy Kearl Fucoidan delivery system
US8426381B2 (en) * 2005-09-09 2013-04-23 Lucas Meyer Cosmetics Canada Inc. Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation
WO2007092620A2 (en) 2006-02-09 2007-08-16 Macusight, Inc. Stable formulations, and methods of their preparation and use
FR2897538B1 (fr) 2006-02-23 2008-05-02 Univ Paris Descartes Utilisation de fucanes a des fins de greffe, d'ingenierie et de regeneration osseuses
PL2001466T3 (pl) 2006-03-23 2016-06-30 Santen Pharmaceutical Co Ltd Rapamycyna w małej dawce do leczenia chorób związanych z przepuszczalnością naczyń
JP4814677B2 (ja) * 2006-03-31 2011-11-16 株式会社荏原製作所 基板保持装置および研磨装置
EP2043685B1 (en) 2006-07-03 2015-12-23 Genmab A/S Prevention of rash in patients undergoing anti-egfr therapy
US8080260B2 (en) 2008-02-13 2011-12-20 The Cleveland Clinic Foundation Molecular enhancement of extracellular matrix and methods of use
US8815953B2 (en) 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
US8410180B2 (en) 2008-04-30 2013-04-02 The Cleveland Clinic Foundation Methods to treat urinary incontinence
JP5819189B2 (ja) * 2009-03-25 2015-11-18 国立大学法人鳥取大学 軟骨生成促進剤および軟骨損傷由来疾病の予防治療剤
JO3676B1 (ar) * 2009-07-27 2020-08-27 Arc Medical Devices Inc مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
KR101528265B1 (ko) * 2010-04-16 2015-06-11 코웨이 주식회사 베타-라파콘을 유효성분으로 포함하는 주름개선용 화장료 조성물
EP2734213B1 (en) * 2011-07-19 2018-06-06 Baxalta GmbH Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
WO2016131824A1 (en) * 2015-02-16 2016-08-25 Xantial Composition for prevention or treatment of cutaneous disorder
WO2017190148A1 (en) * 2016-04-29 2017-11-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for the prevention and treatment of surgical adhesions
US12186334B2 (en) 2018-07-27 2025-01-07 ARC Medical Inc. High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
BR112021000617A2 (pt) 2018-07-27 2021-04-06 Arc Medical Devices Inc. Fucanos com elevado teor de sulfato para o tratamento de aderências fibrosas
MX2021000866A (es) 2019-03-05 2021-06-15 Arc Medical Devices Inc Sistemas y metodos para la filtracion de flujo tangencial de composiciones viscosas.
CN111617030B (zh) * 2020-05-22 2021-09-07 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用
WO2025166450A1 (en) * 2024-02-05 2025-08-14 ARC Medical Inc. Compositions, devices, systems and methods relating to improvement of range of motion in joints

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971848A (en) * 1970-12-21 1976-07-27 Kimitsu Chemical Laboratory Co. Ltd. Lubricating composition for mucosa or epidermis
JPS58147064A (ja) 1982-02-25 1983-09-01 Fuji Electric Co Ltd トランジスタ
EP0293826A3 (en) 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids
JPS6431707A (en) 1987-07-28 1989-02-02 Nikko Chemicals Dermal agent for external use
JPH0714850B2 (ja) 1987-09-29 1995-02-22 喜郎 板谷 化粧料
JPH01313433A (ja) 1988-06-13 1989-12-18 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
JP2853165B2 (ja) * 1989-05-29 1999-02-03 味の素株式会社 体組織癒着防止膜
FR2648463B1 (fr) * 1989-06-14 1993-01-22 Inst Fs Rech Expl Mer Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention
US6096722A (en) * 1990-08-14 2000-08-01 Isis Pharmaceuticals Inc. Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases
US5318890A (en) * 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
JP3403496B2 (ja) 1993-09-24 2003-05-06 株式会社ヤクルト本社 抗潰瘍剤およびヘリコバクター・ピロリの定着阻害剤
JP3545789B2 (ja) * 1993-09-30 2004-07-21 味の素ファルマ株式会社 腹腔内癒着防止剤
FR2772618B1 (fr) * 1997-12-18 2000-02-18 Ifremer Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs
WO2000020642A1 (en) * 1998-10-02 2000-04-13 Genzyme Corporation Prevention of adhesions
JP4267106B2 (ja) * 1998-10-15 2009-05-27 株式会社クラレ 癒着防止用材料
JP2001052309A (ja) 1999-08-06 2001-02-23 Alps Electric Co Ltd 薄膜磁気ヘッドおよびその製造方法
SE0001631D0 (sv) * 2000-05-04 2000-05-04 Sahltech Ab New use

Also Published As

Publication number Publication date
WO2003018033A1 (en) 2003-03-06
EP1420801B1 (en) 2007-10-31
JP2005508893A (ja) 2005-04-07
CN1319540C (zh) 2007-06-06
NZ547609A (en) 2008-07-31
DK1420801T3 (da) 2008-03-03
PT1420801E (pt) 2008-01-17
US20050119216A1 (en) 2005-06-02
US20050074496A1 (en) 2005-04-07
DE60223262T2 (de) 2008-08-14
CN101028283A (zh) 2007-09-05
EP1420801A1 (en) 2004-05-26
CN1547478A (zh) 2004-11-17
ES2295386T3 (es) 2008-04-16
JP4758063B2 (ja) 2011-08-24
KR100910246B1 (ko) 2009-07-31
KR20040032992A (ko) 2004-04-17
ATE376835T1 (de) 2007-11-15
CA2458853C (en) 2010-10-19
HK1066482A1 (en) 2005-03-24
US6812220B2 (en) 2004-11-02
DE60223262D1 (de) 2007-12-13
US20030064958A1 (en) 2003-04-03
JP2009280597A (ja) 2009-12-03
AU2002325113B2 (en) 2006-10-26
CA2458853A1 (en) 2003-03-06
MXPA04001876A (es) 2004-06-15
NZ532015A (en) 2006-12-22
US7163930B2 (en) 2007-01-16

Similar Documents

Publication Publication Date Title
KR100910246B1 (ko) 유착, 관절염 및 건선 치료에 있어서 푸칸의 용도
AU2002325113A1 (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
Kheilnezhad et al. A review: progress in preventing tissue adhesions from a biomaterial perspective
EP1809303B1 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
JP2003525243A (ja) 炎症性疾患の治療のための組成物及び方法
JP2007504273A (ja) 種々の作用剤を用いた、線維性癒着の抑制に関する医薬組成物及び方法
JP2007504273A5 (https=)
JP2013500274A (ja) 線維性癒着及び他の疾患の治療に用いる変性フカンを含む医薬組成物
US20070238697A1 (en) Pharmaceutical compositions and methods relating to fucans
Berkesoglu et al. Topical application of high-dose mesna prevents adhesion formation: an experimental animal study
AU2007200318B2 (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
US20110293691A1 (en) Multimodal adhesion barrier
EP1870105A1 (en) Use of fucans in the treatment of psoriasis
HK1108566A (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
HK1066482B (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
KR101349200B1 (ko) 헥소사민 화합물 또는 이의 약학적으로 허용 가능한 염을포함하는, 수술 후 유착의 예방 또는 치료용 약학 조성물
HK40106155A (zh) 用於治疗与包膜挛缩相关的病症和抑制在移植物周围或移植物上的纤维生长的岩藻聚糖和改性岩藻聚糖组合物
PT2318014T (pt) Nova composição para tratar doenças autoimunes

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20090210

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20090428

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20091030

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20090428

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I